FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2135655504> ?p ?o ?g. }

• W2135655504 endingPage "52" @default.
• W2135655504 startingPage "46" @default.
• W2135655504 abstract "Purpose The use of gold fiducial markers (GFMs) for prostate positioning in high-dose radiotherapy is gaining interest. The purpose of this study was to compare five GFMs regarding feasibility of ultrasound-based implantation in the prostate and intraprostatic lesion (IPL); toxicity; visibility on transabdominal ultrasound (TU) and cone-beam CT (CBCT); reliability of automatic, soft tissue, and GFM-based CBCT patient positioning by comparing manual and automatic fusion CBCT. Methods and Materials Twenty-five patients were included. Pain and toxicity were scored after implantation and high-dose radiotherapy. Fisher exact test was used to evaluate the correlation of patients’ characteristics and prostatitis. Positioning was evaluated on TU and kilovoltage CBCT images. CBCT fusion was performed automatically (Elekta XVI technology, release 3.5.1 b27, based on grey values) and manually on soft tissue and GFMs. Pearson correlation statistics and Bland-Altman evaluation were used. Five GFMs were compared. Results Twenty percent of the patients developed prostatitis despite antibiotic prophylaxis. Cigarette smoking was significantly correlated with prostatitis. The visualization of all GFMs on TU was disappointing. Consequently we cannot recommend the use of these GFMs for TU-based prostate positioning. For all GFMs, there was only fair to poor linear correlation between automatic and manual CBCT images, indicating that even when GFMs are used, an operator evaluation is imperative. However, when GFMs were analyzed individually, a moderate to very strong correlation between automatic and manual positioning was found for larger GFMs in all directions. Conclusion The incidence of prostatitis in our series was high. Further research is imperative to define the ideal preparation protocol preimplantation and to select patients. Automatic fusion is more reliable with larger GFMs at the cost of more scatter. The stability of all GFMs was proven. The use of gold fiducial markers (GFMs) for prostate positioning in high-dose radiotherapy is gaining interest. The purpose of this study was to compare five GFMs regarding feasibility of ultrasound-based implantation in the prostate and intraprostatic lesion (IPL); toxicity; visibility on transabdominal ultrasound (TU) and cone-beam CT (CBCT); reliability of automatic, soft tissue, and GFM-based CBCT patient positioning by comparing manual and automatic fusion CBCT. Twenty-five patients were included. Pain and toxicity were scored after implantation and high-dose radiotherapy. Fisher exact test was used to evaluate the correlation of patients’ characteristics and prostatitis. Positioning was evaluated on TU and kilovoltage CBCT images. CBCT fusion was performed automatically (Elekta XVI technology, release 3.5.1 b27, based on grey values) and manually on soft tissue and GFMs. Pearson correlation statistics and Bland-Altman evaluation were used. Five GFMs were compared. Twenty percent of the patients developed prostatitis despite antibiotic prophylaxis. Cigarette smoking was significantly correlated with prostatitis. The visualization of all GFMs on TU was disappointing. Consequently we cannot recommend the use of these GFMs for TU-based prostate positioning. For all GFMs, there was only fair to poor linear correlation between automatic and manual CBCT images, indicating that even when GFMs are used, an operator evaluation is imperative. However, when GFMs were analyzed individually, a moderate to very strong correlation between automatic and manual positioning was found for larger GFMs in all directions. The incidence of prostatitis in our series was high. Further research is imperative to define the ideal preparation protocol preimplantation and to select patients. Automatic fusion is more reliable with larger GFMs at the cost of more scatter. The stability of all GFMs was proven." @default.
• W2135655504 created "2016-06-24" @default.
• W2135655504 creator A5007857971 @default.
• W2135655504 creator A5045794019 @default.
• W2135655504 creator A5049169579 @default.
• W2135655504 creator A5055056736 @default.
• W2135655504 creator A5065131436 @default.
• W2135655504 creator A5073799244 @default.
• W2135655504 creator A5083566572 @default.
• W2135655504 creator A5091100826 @default.
• W2135655504 date "2012-05-01" @default.
• W2135655504 modified "2023-09-27" @default.
• W2135655504 title "Improving Positioning in High-Dose Radiotherapy for Prostate Cancer: Safety and Visibility of Frequently Used Gold Fiducial Markers" @default.
• W2135655504 cites W1966022555 @default.
• W2135655504 cites W1979891316 @default.
• W2135655504 cites W1982600407 @default.
• W2135655504 cites W1987142623 @default.
• W2135655504 cites W1992743783 @default.
• W2135655504 cites W1993681878 @default.
• W2135655504 cites W1996809772 @default.
• W2135655504 cites W2004080729 @default.
• W2135655504 cites W2012502163 @default.
• W2135655504 cites W2016115074 @default.
• W2135655504 cites W2023613888 @default.
• W2135655504 cites W2033839987 @default.
• W2135655504 cites W2037232743 @default.
• W2135655504 cites W2038551782 @default.
• W2135655504 cites W2040485468 @default.
• W2135655504 cites W2046316783 @default.
• W2135655504 cites W2050465965 @default.
• W2135655504 cites W2052708150 @default.
• W2135655504 cites W2054899405 @default.
• W2135655504 cites W2069367669 @default.
• W2135655504 cites W2080204835 @default.
• W2135655504 cites W2080598191 @default.
• W2135655504 cites W2082530955 @default.
• W2135655504 cites W2083614366 @default.
• W2135655504 cites W2085845883 @default.
• W2135655504 cites W2092752812 @default.
• W2135655504 cites W2093384534 @default.
• W2135655504 cites W2093705034 @default.
• W2135655504 cites W2097532477 @default.
• W2135655504 cites W2116470069 @default.
• W2135655504 cites W2130885411 @default.
• W2135655504 cites W2137388780 @default.
• W2135655504 cites W2141368639 @default.
• W2135655504 cites W2152182740 @default.
• W2135655504 cites W2153962721 @default.
• W2135655504 cites W2157531509 @default.
• W2135655504 cites W2169411122 @default.
• W2135655504 cites W2171855463 @default.
• W2135655504 doi "https://doi.org/10.1016/j.ijrobp.2011.05.058" @default.
• W2135655504 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22014956" @default.
• W2135655504 hasPublicationYear "2012" @default.
• W2135655504 type Work @default.
• W2135655504 sameAs 2135655504 @default.
• W2135655504 citedByCount "10" @default.
• W2135655504 countsByYear W21356555042013 @default.
• W2135655504 countsByYear W21356555042015 @default.
• W2135655504 countsByYear W21356555042016 @default.
• W2135655504 countsByYear W21356555042017 @default.
• W2135655504 countsByYear W21356555042023 @default.
• W2135655504 crossrefType "journal-article" @default.
• W2135655504 hasAuthorship W2135655504A5007857971 @default.
• W2135655504 hasAuthorship W2135655504A5045794019 @default.
• W2135655504 hasAuthorship W2135655504A5049169579 @default.
• W2135655504 hasAuthorship W2135655504A5055056736 @default.
• W2135655504 hasAuthorship W2135655504A5065131436 @default.
• W2135655504 hasAuthorship W2135655504A5073799244 @default.
• W2135655504 hasAuthorship W2135655504A5083566572 @default.
• W2135655504 hasAuthorship W2135655504A5091100826 @default.
• W2135655504 hasConcept C121608353 @default.
• W2135655504 hasConcept C126322002 @default.
• W2135655504 hasConcept C126838900 @default.
• W2135655504 hasConcept C173974348 @default.
• W2135655504 hasConcept C2776235491 @default.
• W2135655504 hasConcept C2779813781 @default.
• W2135655504 hasConcept C2780192828 @default.
• W2135655504 hasConcept C2780524745 @default.
• W2135655504 hasConcept C2989005 @default.
• W2135655504 hasConcept C509974204 @default.
• W2135655504 hasConcept C544519230 @default.
• W2135655504 hasConcept C71924100 @default.
• W2135655504 hasConceptScore W2135655504C121608353 @default.
• W2135655504 hasConceptScore W2135655504C126322002 @default.
• W2135655504 hasConceptScore W2135655504C126838900 @default.
• W2135655504 hasConceptScore W2135655504C173974348 @default.
• W2135655504 hasConceptScore W2135655504C2776235491 @default.
• W2135655504 hasConceptScore W2135655504C2779813781 @default.
• W2135655504 hasConceptScore W2135655504C2780192828 @default.
• W2135655504 hasConceptScore W2135655504C2780524745 @default.
• W2135655504 hasConceptScore W2135655504C2989005 @default.
• W2135655504 hasConceptScore W2135655504C509974204 @default.
• W2135655504 hasConceptScore W2135655504C544519230 @default.
• W2135655504 hasConceptScore W2135655504C71924100 @default.
• W2135655504 hasIssue "1" @default.
• W2135655504 hasLocation W21356555041 @default.
• W2135655504 hasLocation W21356555042 @default.

• next